Coya Therapeutics
(NASDAQ:COYA)
$9.15
0.75[8.93%]
At close: Apr 30
$9.15
0[0.00%]
PreMarket: 5:10PM EDT
Q1 2024 Earnings were released on Thu May 9th, after the market close
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Coya Therapeutics Stock (NASDAQ:COYA), Quotes and News Summary

Coya Therapeutics Stock (NASDAQ: COYA) stock price, news, charts, stock research, profile.

Open-
Close-
Volume / Avg.0 / 92.741K
Day Range- - -
52 Wk Range3.210 - 10.690
Market Cap$133.756M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
58
Short Interest
1.37%
Days to Cover3.21

Recent News

Sponsored
Coya Therapeutics Secures Key Financing In Its Fight Against Myriad Diseases
Dr. Howard Berman, Ph.D, CEO of Coya Therapeutics Inc (NASDAQ: COYA), were guests on Benzinga’s All Access.
Coya Therapeutics' Alzheimer's Candidate Shows Lower Biomarker Levels Associated With Neuroinflammation
Coya Therapeutics Inc (NASDAQ: COYA) reported results from an open-label proof-of-concept clinical study for low-dose interleukin 2 (ld IL-2) in patients 
Vandana Singh
Sponsored
The Immunotherapy Market Is Expected To Surpass $351.56 Billion By 2030 – Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) Is Contributing to This Growth
Immunotherapy, in general, is an exciting and growing sector in the pharmaceutical industry. It involves manipulating the human body's immune system to treat various diseases. While historically this type of manipulation has been associated with cancer treatments, innovative companies are applying the same principles to a wide variety of diseases. 
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Mar
1
Apr
1
May
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
COYA
MOLN

FAQ

Q

How do I buy Coya Therapeutics (COYA) stock?

A

You can purchase shares of Coya Therapeutics (NASDAQ: COYA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Coya Therapeutics's (COYA) competitors?

A

Other companies in Coya Therapeutics’s space includes: Molecular Partners (NASDAQ:MOLN), Renovaro (NASDAQ:RENB), Cellectar Biosciences (NASDAQ:CLRB), FibroGen (NASDAQ:FGEN) and Vistagen Therapeutics (NASDAQ:VTGN).

Q

What is the target price for Coya Therapeutics (COYA) stock?

A

The latest price target for Coya Therapeutics (NASDAQ: COYA) was reported by Chardan Capital on Thursday, May 9, 2024. The analyst firm set a price target for 14.00 expecting COYA to rise to within 12 months (a possible 53.01% upside). 12 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Coya Therapeutics (COYA)?

A

The stock price for Coya Therapeutics (NASDAQ: COYA) is $9.15 last updated April 30, 2024 at 5:10 PM EDT.

Q

Does Coya Therapeutics (COYA) pay a dividend?

A

There are no upcoming dividends for Coya Therapeutics.

Q

When is Coya Therapeutics (NASDAQ:COYA) reporting earnings?

A

Coya Therapeutics’s Q2 earnings are confirmed for Tuesday, August 6, 2024.

Q

Is Coya Therapeutics (COYA) going to split?

A

There is no upcoming split for Coya Therapeutics.

Q

What sector and industry does Coya Therapeutics (COYA) operate in?

A

Coya Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch